Benzinga | Jul 21, 2020 06:06AM EDT

Barclays Initiates Coverage On PolyPid with Overweight Rating, Announces Price Target of $22

Barclays initiates coverage on PolyPid (NASDAQ:PYPD) with a Overweight rating and announces Price Target of $22.